CDMRP: Neurofibromatosis Research Program (NFRP): Clinical Trial Award, Exploration-Hypothesis Development Award, Investigator-Initiated Research Award, New Investigator Award

-Clinical Trial Award: Funds Phase 0, I, or II clinical trials relevant to NF and/or schwannomatosis. Combinations of phases are permitted. Funding: $900K over 4 yrs. http://www.grants.gov/web/grants/view-opportunity.html?oppId=276380  
-Exploration - Hypothesis Development Award: Supports initial innovative high-risk high-return gain concepts in NF research to lay the groundwork for future avenues of investigation. Funding: $100K over 2 yrs. http://www.grants.gov/web/grants/view-opportunity.html?oppId=276382  
-Investigator-Initiated Research Award: Supports highly rigorous, high impact research with the potential to make an important contribution to NF research and/or patient care Preliminary or published data required, clinical trials not allowed. Funding: $525-575K over 3 yrs. http://www.grants.gov/web/grants/view-opportunity.html?oppId=276385  
-New Investigator Award: Supports the continued development of promising independent investigators and/or the transition of established investigators into a career in NF research. Funding: $400K over 3 yrs.http://www.grants.gov/web/grants/view-opportunity.html?oppId=27638 7

Topic areas:

- Health services research for NF (see definition below)
- Heterogeneity of neurofibromas and other NF-related tumors
- Manifestations of NF post-adolescence
- Mechanisms of pain
- Novel disease and treatment response markers for NF using genomics, epigenetics, systems biology, metabolomics, or other similar approaches
- Target identification and drug discovery for the treatment of NF
- Environmental, nutritional, and other modifiers of NF

https://ebrap.org/eBRAP/public/Program.htm